8-K - ANAVEX LIFE SCIENCES CORP. (0001314052) (Filer)
Published . Updated .
Key takeaways
- 8-K - ANAVEX LIFE SCIENCES filed an 8-K with the SEC on Nov 3 (a notice of a material company event).
- Exposed: AVXL
- Market reaction: AVXL +0.4% after three sessions
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - ANAVEX LIFE SCIENCES filed an 8-K with the SEC on Nov 3 (a notice of a material company event).
Directly affected
- AVXL Anavex Life Sciences-43.4% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Anavex Life Sciences belongs to, so it often moves with news about it.
- AMGN Amgen+10.3% 30d
Amgen is a peer of Anavex Life Sciences in biological products, (no diagnostic substances); rivals often move on the same news.
- GILD Gilead Sciences+18.5% 30d
Gilead Sciences is a peer of Anavex Life Sciences in biological products, (no diagnostic substances); rivals often move on the same news.
- MRNA Moderna+23.2% 30d
Moderna is a peer of Anavex Life Sciences in biological products, (no diagnostic substances); rivals often move on the same news.
- ARGX argenx SE-11.9% 9d
argenx SE is a peer of Anavex Life Sciences in biological products, (no diagnostic substances); rivals often move on the same news.
- RVMD Revolution Medicines
Revolution Medicines is a peer of Anavex Life Sciences in biological products, (no diagnostic substances); rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| AVXL | +13.54% | +13.54% | base | +5.24% | +9.17% | -3.93% | +0.44% |
| XLV | -2.95% | -0.31% | base | -0.34% | +2.73% | +0.31% | +0.13% |
| AMGN | -3.75% | -1.04% | base | -0.92% | +2.72% | -1.06% | -0.89% |
| GILD | -6.65% | -2.82% | base | -1.70% | +2.38% | -1.69% | -1.64% |
| MRNA | -5.90% | +0.84% | base | +3.40% | +16.98% | +9.28% | +19.24% |
| ARGX | +0.87% | +2.64% | base | +3.02% | +6.49% | +2.22% | +5.44% |
| RVMD | -1.02% | +1.20% | base | +3.19% | +6.03% | -5.48% | +3.37% |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-03 AccNo: 0001731122-26-001395 Size: 208 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial St…
Source: sec-edgar
Anavex Life Sciences (AVXL)
Those 5 earlier stories put Anavex Life Sciences (AVXL) at an average move of -1.01% the next day. Largest gain +9.17%, largest drop -14.97%, from 5 prices.
| Company | When | Average | Largest gain | Largest drop | Prices |
|---|---|---|---|---|---|
| Anavex Life Sciences (AVXL) | the next day | -1.01% | +9.17% | -14.97% | 5 |
| Anavex Life Sciences (AVXL) | three days later | -2.92% | +0.44% | -7.82% | 5 |
- 8-K - ANAVEX LIFE SCIENCES CORP. (0001314052) (Filer)
- 8-K - ANAVEX LIFE SCIENCES CORP. (0001314052) (Filer)
- 8-K - ANAVEX LIFE SCIENCES CORP. (0001314052) (Filer)
- Latham Advises on Financing for Altaris’ Completed Acquisition of Clarivate’s Life Sciences & Healthcare Business
- Life & Banc Split Corp A 2006-29.11.18 Ext to 30.10.23 Further Ext to 30.10.28
The price since 3 Nov 2026: Anavex Life Sciences (AVXL) versus the S&P 500
Since the first closing price after “8-K - ANAVEX LIFE SCIENCES CORP. (0001314052) (Filer),” Anavex Life Sciences (AVXL) is -9.52%.
| Company | When | Move | Status |
|---|---|---|---|
| AMGN | that day | -0.92% | final price |
| AMGN | the next day | +2.72% | final price |
| AMGN | two days later | -1.06% | final price |
| AMGN | three days later | -0.89% | final price |
| AMGN | three days earlier | -1.04% | final price |
| AMGN | five days earlier | -3.75% | final price |
| ARGX | that day | +3.02% | final price |
| ARGX | the next day | +6.49% | final price |
| ARGX | two days later | +2.22% | final price |
| ARGX | three days later | +5.44% | final price |
| ARGX | three days earlier | +2.64% | final price |
| ARGX | five days earlier | +0.87% | final price |
| Anavex Life Sciences (AVXL) | that day | +5.24% | final price |
| Anavex Life Sciences (AVXL) | the next day | +9.17% | final price |
| Anavex Life Sciences (AVXL) | two days later | -3.93% | final price |
| Anavex Life Sciences (AVXL) | three days later | +0.44% | final price |
| Anavex Life Sciences (AVXL) | three days earlier | +13.54% | final price |
| Anavex Life Sciences (AVXL) | five days earlier | +13.54% | final price |
| GILD | that day | -1.70% | final price |
| GILD | the next day | +2.38% | final price |
| GILD | two days later | -1.69% | final price |
| GILD | three days later | -1.64% | final price |
| GILD | three days earlier | -2.82% | final price |
| GILD | five days earlier | -6.65% | final price |
| MRNA | that day | +3.40% | final price |
| MRNA | the next day | +16.98% | final price |
| MRNA | two days later | +9.28% | final price |
| MRNA | three days later | +19.24% | final price |
| MRNA | three days earlier | +0.84% | final price |
| MRNA | five days earlier | -5.90% | final price |
| RVMD | that day | +3.19% | final price |
| RVMD | the next day | +6.03% | final price |
| RVMD | two days later | -5.48% | final price |
| RVMD | three days later | +3.37% | final price |
| RVMD | three days earlier | +1.20% | final price |
| RVMD | five days earlier | -1.02% | final price |
| XLV | that day | -0.34% | final price |
| XLV | the next day | +2.73% | final price |
| XLV | two days later | +0.31% | final price |
| XLV | three days later | +0.13% | final price |
| XLV | three days earlier | -0.31% | final price |
| XLV | five days earlier | -2.95% | final price |
Trades by members of Congress and officials in the stocks in this story
- Sen. Sheldon Whitehouse sold Amgen (AMGN) (held by a spouse), worth $15,001 - $50,000 on 15 Oct 2026. That is 19 days before publication. Filed 2 Nov 2026. View the filing.
- Rep. David J. Taylor bought Amgen (AMGN), worth $1,001 - $15,000 on 22 Sep 2026. That is 42 days before publication. Filed 1 Oct 2026. View the filing.
- Rep. David J. Taylor sold Amgen (AMGN), worth $1,001 - $15,000 on 26 Aug 2026. That is 69 days before publication. Filed 5 Sep 2026. View the filing.
- Rep. Rohit Khanna sold Gilead Sciences (GILD) (held by a dependent child), worth $1,001 - $15,000 on 10 Aug 2026. That is 85 days before publication. Filed 4 Sep 2026. View the filing.
- Rep. Maria Elvira Salazar sold Moderna (MRNA), worth $1,001 - $15,000 on 24 Sep 2026. That is 40 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Moderna (MRNA) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 60 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Moderna (MRNA), worth $1,001 - $15,000 on 28 Aug 2026. That is 67 days before publication. Filed 8 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - ANAVEX LIFE SCIENCES CORP. (0001314052) (Filer)”
Companies carried with this story
- AVXL Anavex Life Sciences
In “8-K - ANAVEX LIFE SCIENCES CORP. (0001314052) (Filer),” Anavex Life Sciences (AVXL) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> AVXL
How “8-K - ANAVEX LIFE SCIENCES CORP. (0001314052) (Filer)” reaches Anavex Life Sciences (AVXL)
On 3 Nov 2026, “8-K - ANAVEX LIFE SCIENCES CORP. (0001314052) (Filer)” is the story that connects Anavex Life Sciences (AVXL) to this story.
What ties Anavex Life Sciences (AVXL) to the headline is this: SEC 8-K filing -> direct issuer disclosure -> AVXL
The price range for Anavex Life Sciences (AVXL), and the dates in the story
AVXL traded between 1.07 and 1.55 across 20 sessions. The latest close on file is 1.14.
What the saved facts support for Anavex Life Sciences (AVXL)
14 out of 100
“8-K - ANAVEX LIFE SCIENCES CORP. (0001314052) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.